Johnson & Johnson

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. TD Ameritrade’s Investor Movement Index (IMX) — a monthly behavior-based index that indicates the attitude of retail investors...

Besides saving lives and the global economy, we are expecting three things from the upcoming COVID-19 vaccine: safety, immunogenicity and efficacy. But we never had a 100 percent efficacy when it comes to respiratory viruses, so anything between 50 and 100% will be the best we've got as the WHO...

Despite not including electrifying stocks such as Amazon.com, Inc. (NASDAQ: AMZN), and therefore missing out on its historical gains, the Dow Jones Index still has quite a few winners under its umbrella. Although Apple Inc (NASDAQ: AAPL) and Microsoft Corporation (NASDAQ: MSFT) had their worst...

This weekend's Barron's looks at homebuilder stocks that are poised to soar. Other featured articles focus on COVID-19 stocks, real estate investment trusts and disruptive global tech companies. Also, the prospects for a fast-food giant, an auto parts leader, a top software provider and...

Key Takeaways: Earnings week kicks off with JP Morgan Chase, Wells Fargo, and Citigroup reporting Concerns about an increase in coronavirus cases keep investors on shaky ground Market uncertainty still looms but broader markets above key support levels (Tuesday Market Open) After weeks of...

This weekend's Barron's cover story shows how the race for a COVID-19 vaccine could affect investors. Other featured articles look at stocks involved in the race for 5G and some value stocks that are worth a look now. Also, the prospects for an online retailer, a networking stock, video...

The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Until recently, innovation lay dormant in the quality-driven cannabis industry. However, an evolving regulatory environment, coupled with...

It seems that Johnson & Johnson (NYSE: JNJ) has finally started shaking off those heavy legal headwinds. Accusations of tainted baby powder was just the latest chapter in its long book of controversy. Although the complicated legal process can drag on for years, its stock has posted a 6% return...

Pharmaceutical companies are in trouble over their role in fueling the opioid crisis facing the U.S. What Happened Federal authorities have launched a criminal investigation against the companies — using the same laws used to prosecute drug dealers, the Wall Street Journal reported ...

This weekend's Barron's cover story explains how to generate income in retirement. Other featured articles discuss big tech's take on banking and retailers that have been left behind. Also, the prospects for a medical devices maker, a financial services play, a retail giant still...

This weekend's Barron's cover story suggests how to play the streaming TV revolution. Other featured articles discuss the effect of lower enterprise tech spending and offer dividend stock picks for a low-rate world. Also, the prospects for an oil giant, an optical retailer, a beleaguered...

Benzinga has examined the prospects for many investor favorite stocks over the past week. Bullish calls included a second-tier telecom and a fast-casual restaurant leader. Bearish calls included beleaguered health care giant and an international bank. The third-quarter earnings reporting season...

Benzinga has examined prospects for many investor favorite stocks over the past week. Bullish calls included leaders in the aerospace, media and retail sectors. Some bearish calls were prompted by quarterly earnings reports. The second-quarter earnings reporting season kicked off this past week,...